MSH Is Building Health Workers' Skills in Malawi to Institute New Malaria Treatment Policy

In 2006, the Malawi Ministry of Health chose the artemisinin-based combination therapy artemether-lumefantrine as the first-line drug for treating uncomplicated malaria. However, when Malawi officially launched the policy nationwide, one of the greatest challenges was a lack of capacity among health workers and pharmacy personnel to manage the new treatment.

By training several hundreds of health workers in dispensing and maintaining proper patient records in Malawi, MSH's Strengthening Pharmaceutical Systems project, with funding from the President's Malaria Initiative (PMI), assisted in ensuring health centers are carrying out proper pharmaceutical management practices for artemether-lumefantrine and other essential medicines.

Read the recent feature article on PMI's website.

 

Printer Friendly VersionPDF